Search results
CULVER CITY, Calif., June 07, 2024--ImmunityBio, Inc. (NASDAQ: IBRX) announced today that its 2024 Annual Meeting of Stockholders will be held on Tuesday, June 11, 2024 at 9:30 a.m. Pacific Time ...
IBRX stock has fallen by 16.40% compared to the previous week, the month change is a 5.14% fall, over the last year ImmunityBio, Inc. has showed a 132.22% increase. What is IBRX stock forecast? We've gathered analysts' opinions on ImmunityBio, Inc. future price: according to them, IBRX price has a max estimate of 9.00 USD and a min estimate of ...
Jun 25, 2024 · We forecast ImmunityBio stock performance using neural networks based on historical data on IBRX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
ImmunityBio (IBRX) is a biotech company developing novel therapies for cancer and infectious diseases. Find out the latest news, analyst forecasts and price target on TipRanks.com.
ImmunityBio Stock Forecast. Over the next 52 weeks, ImmunityBio has on average historically risen by 123.7% based on the past 8 years of stock performance. Is ImmunityBio Stock Undervalued? The current ImmunityBio [ IBRX] share price is $6.54. The Score for IBRX is 58, which is 16% above its historic median score of 50, and infers lower risk ...
ImmunityBio Stock Forecast, IBRX stock price prediction. Price target in 14 days: 7.217 USD. The best long-term & short-term ImmunityBio share price prognosis for ...
See ImmunityBio, Inc. (IBRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
